+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polidocanol"

Polidocanol Injection Market by Product Type (Foam polidocanol, Liquid polidocanol), Concentration Levels (0.5% Solution, 1% Solution, 3% Solution), Package Form, Application, Age Group, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Polidocanol Injection Market by Product Type (Foam polidocanol, Liquid polidocanol), Concentration Levels (0.5% Solution, 1% Solution, 3% Solution), Package Form, Application, Age Group, End User - Global Forecast 2025-2030

  • Report
  • March 2025
  • 188 Pages
  • Global
From
Varicose Veins Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Varicose Veins Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 130 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Polidocanol is a sclerosing agent used in the treatment of cardiovascular diseases. It is a synthetic, non-ionic surfactant that is injected into the affected area to reduce the diameter of the vessel and improve blood flow. It is used to treat varicose veins, spider veins, and other vascular malformations. It is also used to treat arterial occlusions, such as those caused by atherosclerosis. Polidocanol is a safe and effective treatment for cardiovascular diseases, with minimal side effects. Polidocanol is available in a variety of formulations, including injectable solutions, foam, and topical creams. It is also available in combination with other drugs, such as heparin, to enhance its efficacy. Several companies are involved in the production and distribution of Polidocanol. These include Bayer, Merck, Sanofi, and Novartis. Show Less Read more